657-05-6

Basic information

• Product Name: 2-CHLORO-5-(TRIFLUOROMETHYL)BENZOYL CHLORIDE
• Synonyms: 2-CHLORO-5-(TRIFLUOROMETHYL)BENZOYL CHLORIDE;6-Chloro-alpha,alpha,alpha-trifluoro-m-toluoyl chloride;[2-chloro-5-(trifluoroMethyl)phenyl]carbonylchloranuide
• CAS NO: 657-05-6
• Molecular Formula: C₈H₃Cl₂F₃O
• Molecular Weight: 243.01
• EINECS: -0
• Mol File: 657-05-6.mol

Chemical Properties

• Boiling Point: 59-61°C 1mm
• Flash Point: 59-61°C/1mm
• Appearance: /
• Density: 1.506
• Vapor Pressure: 0.0503mmHg at 25°C
• Refractive Index: 1.497
• Storage Temp.: Inert atmosphere,Room Temperature
• Sensitive: Moisture Sensitive
• BRN: 1878576
• CAS DataBase Reference: 2-CHLORO-5-(TRIFLUOROMETHYL)BENZOYL CHLORIDE(CAS DataBase Reference)
• NIST Chemistry Reference: 2-CHLORO-5-(TRIFLUOROMETHYL)BENZOYL CHLORIDE(657-05-6)
• EPA Substance Registry System: 2-CHLORO-5-(TRIFLUOROMETHYL)BENZOYL CHLORIDE(657-05-6)

Safety Data

• Hazard Codes: C,Xn
• Statements: 34-36/37/38-22
• Safety Statements: 26-36/37/39
• RIDADR: 3265
• HazardClass: 8
• PackingGroup: II
• Hazardous Substances Data: 657-05-6(Hazardous Substances Data)

Usage

Uses

Used in Organic Synthesis:
2-Chloro-5-(trifluoromethyl)benzoyl chloride is used as a reagent for various organic synthesis processes due to its unique properties and reactivity.
Used in Pharmaceutical Industry:
2-Chloro-5-(trifluoromethyl)benzoyl chloride is used as an ingredient in the manufacture of pharmaceuticals for its contribution to the synthesis of certain drug compounds.
Used in Agrochemical Industry:
2-Chloro-5-(trifluoromethyl)benzoyl chloride is used as a component in the production of agrochemicals, aiding in the synthesis of specific agrochemical products.
Used in Polymer Industry:
2-Chloro-5-(trifluoromethyl)benzoyl chloride is used in the synthesis of certain types of polymers, contributing to the development of unique polymeric materials.

InChI:InChI=1/C8H3Cl2F3O/c9-6-2-1-4(8(11,12)13)3-5(6)7(10)14/h1-3H

Upstream product

• 657-06-7 2-chloro-5-trifluoromethylbenzoic acid 
• 454-78-4 3-bromo-4-chlorobenzotrifluoride 
• 98-56-6 4-chlorobenzotrifluoride 
• 328-87-0 2-chloro-5-(trifluoromethyl)benzonitrile 
• 121-50-6 3-amino-4-chlorobenzotrifluoride 
• 79-37-8 oxalyl dichloride 

Downstream Products

• 1858-71-5 2-Chloro-2',5-bis-(trifluoromethyl)-benzophenone 
• 501442-36-0 2-chloro-N-(pyridin-4-yl)-5-(trifluoromethyl)benzamide 
• 1240016-20-9 N-[(2-allyl-2-azabicyclo[2.1.1]hex-1-yl)(phenyl)methyl]-2-chloro-5-(trifluoro-methyl)benzamide 
• 1207529-63-2 trans-4-(2-chloro-5-trifluoromethyl-benzoylamino)-cyclohexane carboxylic acid methyl ester 

Relevant articles and documents

Synthesis and biological evaluation of 1,2,4-triazole-3-thione and 1,3,4-oxadiazole-2-thione as antimycobacterial agents

Resistance among dormant mycobacteria leading to multidrug-resistant and extremely drug-resistant tuberculosis is one of the major threats. Hence, a series of 1,2,4-triazole-3-thione and 1,3,4-oxadiazole-2-thione derivatives (4a–5c) have been synthesized and screened for their antitubercular activity against Mycobacterium tuberculosis H37Ra (H37Ra). The triazolethiones 4b and 4v showed high antitubercular activity (both MIC and IC50) against the dormant H37Ra by in vitro and ex vivo. They were shown to have more specificity toward mycobacteria than other Gram-negative and Gram-positive pathogenic bacteria. The cytotoxicity was almost insignificant up to 100?μg/ml against THP-1, A549, and PANC-1 human cancer cell lines, and solubility was high in aqueous solution, indicating the potential of developing these compounds further as novel therapeutics against tuberculosis infection.

Structure-Based Optimization of a Small Molecule Antagonist of the Interaction between WD Repeat-Containing Protein 5 (WDR5) and Mixed-Lineage Leukemia 1 (MLL1)

WD repeat-containing protein 5 (WDR5) is an important component of the multiprotein complex essential for activating mixed-lineage leukemia 1 (MLL1). Rearrangement of the MLL1 gene is associated with onset and progression of acute myeloid and lymphoblastic leukemias, and targeting the WDR5-MLL1 interaction may result in new cancer therapeutics. Our previous work showed that binding of small molecule ligands to WDR5 can modulate its interaction with MLL1, suppressing MLL1 methyltransferase activity. Initial structure-activity relationship studies identified N-(2-(4-methylpiperazin-1-yl)-5-substituted-phenyl) benzamides as potent and selective antagonists of this protein-protein interaction. Guided by crystal structure data and supported by in silico library design, we optimized the scaffold by varying the C-1 benzamide and C-5 substituents. This allowed us to develop the first highly potent (Kdisp 100 nM) small molecule antagonists of the WDR5-MLL1 interaction and demonstrate that N-(4-(4-methylpiperazin-1-yl)-3′-(morpholinomethyl)-[1,1′-biphenyl]-3-yl)-6-oxo-4-(trifluoromethyl)-1,6-dihydropyridine-3-carboxamide 16d (OICR-9429) is a potent and selective chemical probe suitable to help dissect the biological role of WDR5.

Syntheses and studies of new forms of N-sulfonyloxy β-lactams as potential antibacterial agents and β-lactamase inhibitors

The synthesis of a small library of N-sulfonyloxy-2-azetidinones is reported and the preliminary results of the investigation of the biological activity of these molecules are discussed. These new multi-electrophilic β-lactams ('electrophilic bombs') disp

ALPHA-(TRIFLUOROMETHYL-SUBSTITUTED ARYLOXY, ARYLAMINO, ARYLTHIO OR ARYLMETHYL)-TRIFLUOROMETHYL-SUBSTITUTED PHENYLACETIC ACIDS AND DERIVATIVES AS ANTIDIABETIC AGENTS

Compounds having a formula (1) or a pharmaceutically acceptable salt or prodrug thereof, are provided, and are useful for the treatment of metabolic disorders.

Heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists

The present invention provides compounds and pharmaceutical compositions that act as antagonists at metabotropic glutamate receptors, and that are useful for treating neurological diseases and disorders. Methods of preparing the compounds also are disclosed.

Synthesis of racemic 1,2,3,4-tetrahydroisoquinolines and their resolution

1-Aniline-substituted 3,4-dihydroisoquinolines were obtained in various ways using the Bischler-Napieralski reaction. The effect of the protecting group at the aniline nitrogen atom on the course of the reaction has been studied and it was found that the N-phthalyl group was stable under the cyclization conditions. The dihydroisoquinolines were reduced to the racemic 1,2,3,4-tetrahydroisoquinolines which were resolved by crystallization of the diastereomeric tartrates. Two examples of 1,2,3, 4-tetrahydroisoquinolines were obtained in optically pure form (>99% ee).